i read their 2013 report under their investor website, no partner mentioned yet,
http://www.oxfordbiomedica.co.uk/upl...b-agm-2013.pdf

they are partnering with SANOFI on other products.

the patient is much improved, the question is she doing better than a DBS?

that seemed to be the issue with neurologix?

it's great that she says she's gradually improving which is definately better than DBS but she didn't look or sound any better just sitting there compared to previous video of her after the operation and one would think if many more patients were also improving you'd hear about it. she said she is taking fewer meds but like you say, talk is cheap.

just playing devil's advocate, one would assume MJFF, big pharma is following them closely, maybe they aren't ready to partner?